Sally A Holland, PA
Physician Assistant · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · One Medical Group Inc · 330 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Sally A Holland’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence G57397 · Current
Licensed to practise in California · since 1986 · expires 2028-01-31 · Vanderbilt University School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$3,330
Medicare paid this office $3,330 for 18 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 12 | $1,599 | $89 |
Who their Medicare patients are
18 Original Medicare patients in 2024. Average age 73 · Health risk score 0.96. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
The office billed $24,156, Medicare allowed $4,328 and paid $3,330; for 54 services of 17 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 18 | 54 | 73 | 0.96 | $24,156 | $3,330 |
| 2023 | 41 | 67 | 73 | 0.76 | $37,958 | $4,708 |
| 2022 | 35 | 78 | 73 | 0.64 | $39,460 | $5,320 |
| 2021 | 34 | 57 | 72 | 0.61 | $24,980 | $3,662 |
| 2020 | 22 | 32 | 73 | 0.57 | $12,955 | $1,985 |
| 2017 | 12 | 54 | 67 | 1.17 | $1,163 | $424 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 17 | $1,964 | $94 |
| Short return visit (20+ min) | 18 | $1,510 | $63 |
2022: 2 services
| Return visit (30+ min) | 18 | $2,519 | $87 |
| Short return visit (20+ min) | 22 | $2,030 | $70 |
2021: 2 services
| Return visit (30+ min) | 14 | $1,432 | $102 |
| Short return visit (20+ min) | 16 | $1,188 | $63 |
2017: 1 service
| Blood glucose (sugar) level | 12 | $158 | $5 |
Medicaid work
$5,506 in 2019
Medicaid paid $5,506 for 219 billed services this clinician did in 2019, up to 26 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 86 | $5,505 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 73 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 60 | $0 |
| 2019 | 219 | 3 | 26 | $5,506 |
| 2018 | 680 | 5 | 38 | $17,217 |
See the largest Medicaid services in earlier years
2018
| Short return visit (20+ min) | 243 | $16,932 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 12 | $259 |
| HEMOGLOBIN | 12 | $24 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 232 | $1 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 181 | $1 |
Drugs they prescribed that Part D paid
$22,187
Pharmacies billed $22,187 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
109 generic and fewer than 11 brand-name prescriptions · $22,187 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gabapentin | 11 | $121 | $11 |
Year by year
| 2024 | 130 | 28 | None | None | $22,187 |
| 2023 | 218 | 42 | None | None | $33,803 |
| 2022 | 169 | 29 | 0% (0) | None | $20,818 |
| 2021 | 51 | 22 | 0% (0) | None | $3,860 |
| 2020 | 66 | 28 | 0% (0) | None | $4,487 |
| 2019 | 547 | 50 | 0% (0) | 13% | $30,867 |
| 2018 | 954 | 61 | None | 16% | $68,488 |
| 2017 | 745 | 57 | None | 20% | $43,448 |
| 2016 | 796 | 73 | None | 22% | $49,683 |
| 2015 | 596 | 58 | 0% (0) | 22% | $37,127 |
| 2014 | 915 | 72 | None | 24% | $57,311 |
| 2013 | 400 | 52 | None | None | $20,163 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Atorvastatin | 12 | $106 | $9 |
2022: 2 drugs
| Losartan | 12 | $256 | $21 |
| Amlodipine Besylate | 11 | $205 | $19 |
2020: 1 drug
| Atorvastatin | 11 | $107 | $10 |
2019: 15 drugs
| Trulicity | 15 | $11,330 | $755 |
| Basaglar Kwikpen U-100 | 13 | $2,667 | $205 |
| Albuterol Sulfate Hfa | 13 | $656 | $50 |
| Atorvastatin | 74 | $552 | $7 |
| Metoprolol | 33 | $394 | $12 |
| Nifedipine Er | 15 | $247 | $16 |
| Metformin | 36 | $162 | $5 |
| Simvastatin | 16 | $93 | $6 |
| Lisinopril | 21 | $86 | $4 |
| Gabapentin | 11 | $75 | $7 |
| Amlodipine Besylate | 36 | $66 | $2 |
| Hydrochlorothiazide | 37 | $64 | $2 |
| Ranitidine | 15 | $62 | $4 |
| Losartan | 18 | $48 | $3 |
| Lisinopril-Hydrochlorothiazide | 11 | $28 | $3 |
2018: 27 drugs
| Trulicity | 28 | $22,917 | $818 |
| Janumet | 30 | $13,820 | $461 |
| Basaglar Kwikpen U-100 | 17 | $3,498 | $206 |
| Ventolin Hfa | 14 | $863 | $62 |
| Metoprolol | 56 | $834 | $15 |
| Atorvastatin | 104 | $770 | $7 |
| Alcohol Pads | 18 | $608 | $34 |
| Pro Comfort Alcohol Pads | 11 | $549 | $50 |
| Ammonium Lactate | 18 | $478 | $27 |
| Nifedipine Er | 21 | $273 | $13 |
| Metformin | 52 | $245 | $5 |
| Amlodipine Besylate | 44 | $206 | $5 |
| Amlodipine Besylate-Benazepril | 13 | $200 | $15 |
| Triamcinolone Acetonide | 13 | $177 | $14 |
| Losartan | 30 | $148 | $5 |
| Lisinopril | 53 | $146 | $3 |
| Ranitidine | 23 | $139 | $6 |
| Hydrochlorothiazide | 56 | $134 | $2 |
| Metformin Hcl Er | 14 | $111 | $8 |
| Lisinopril-Hydrochlorothiazide | 19 | $104 | $5 |
| Simvastatin | 22 | $94 | $4 |
| Famotidine | 13 | $86 | $7 |
| Glipizide | 18 | $68 | $4 |
| Montelukast | 11 | $65 | $6 |
| Carvedilol | 12 | $45 | $4 |
| Atenolol | 11 | $42 | $4 |
| Gabapentin | 13 | $26 | $2 |
2017: 21 drugs
| Januvia | 19 | $9,427 | $496 |
| Janumet | 15 | $5,772 | $385 |
| Symbicort | 12 | $3,587 | $299 |
| Lantus Solostar | 12 | $2,827 | $236 |
| Ventolin Hfa | 23 | $1,202 | $52 |
| Atorvastatin | 56 | $443 | $8 |
| Gabapentin | 18 | $372 | $21 |
| Metoprolol | 16 | $255 | $16 |
| Nifedipine Er | 11 | $210 | $19 |
| Metformin | 43 | $205 | $5 |
| Montelukast | 19 | $176 | $9 |
| Lisinopril | 37 | $163 | $4 |
| Valsartan-Hydrochlorothiazide | 13 | $158 | $12 |
| Omeprazole | 19 | $149 | $8 |
| Amlodipine Besylate | 34 | $100 | $3 |
| Naproxen | 11 | $80 | $7 |
| Hydrochlorothiazide | 35 | $74 | $2 |
| Simvastatin | 28 | $71 | $3 |
| Lisinopril-Hydrochlorothiazide | 19 | $57 | $3 |
| Atenolol | 12 | $28 | $2 |
| Furosemide | 12 | $15 | $1 |
2016: 22 drugs
| Januvia | 15 | $5,298 | $353 |
| Lantus Solostar | 14 | $4,859 | $347 |
| Flovent Hfa | 11 | $2,842 | $258 |
| Ventolin Hfa | 26 | $1,334 | $51 |
| Lidocaine-Prilocaine | 29 | $1,053 | $36 |
| Omega-3 Acid Ethyl Esters | 12 | $794 | $66 |
| Alcohol Pads | 14 | $789 | $56 |
| Celecoxib | 12 | $781 | $65 |
| Atorvastatin | 33 | $245 | $7 |
| Montelukast | 12 | $127 | $11 |
| Metformin | 43 | $123 | $3 |
| Simvastatin | 46 | $118 | $3 |
| Metformin Hcl Er | 16 | $113 | $7 |
| Ranitidine | 16 | $104 | $6 |
| Ibuprofen | 20 | $103 | $5 |
| Lisinopril | 35 | $89 | $3 |
| Losartan-Hydrochlorothiazide | 16 | $80 | $5 |
| Lisinopril-Hydrochlorothiazide | 31 | $78 | $3 |
| Hydrochlorothiazide | 30 | $74 | $2 |
| Amlodipine Besylate | 33 | $67 | $2 |
| Atenolol | 12 | $35 | $3 |
| Glipizide | 13 | $25 | $2 |
2015: 17 drugs
| Lidocaine-Prilocaine | 26 | $993 | $38 |
| Proair Hfa | 14 | $720 | $51 |
| Tamsulosin | 13 | $272 | $21 |
| Ammonium Lactate | 11 | $234 | $21 |
| Levothyroxine | 13 | $230 | $18 |
| Montelukast | 15 | $153 | $10 |
| Atorvastatin | 19 | $130 | $7 |
| Simvastatin | 37 | $127 | $3 |
| Metformin | 24 | $116 | $5 |
| Omeprazole | 18 | $97 | $5 |
| Lisinopril | 27 | $93 | $3 |
| Lisinopril-Hydrochlorothiazide | 15 | $71 | $5 |
| Losartan-Hydrochlorothiazide | 11 | $59 | $5 |
| Amlodipine Besylate | 24 | $52 | $2 |
| Glipizide | 14 | $39 | $3 |
| Metoprolol | 11 | $34 | $3 |
| Hydrochlorothiazide | 14 | $32 | $2 |
2014: 24 drugs
| Advair Diskus | 26 | $9,837 | $378 |
| Lantus Solostar | 12 | $3,961 | $330 |
| Flovent Hfa | 15 | $2,801 | $187 |
| Proair Hfa | 24 | $1,178 | $49 |
| Ventolin Hfa | 22 | $998 | $45 |
| Lidocaine-Prilocaine | 19 | $606 | $32 |
| Montelukast | 25 | $575 | $23 |
| Metformin | 69 | $413 | $6 |
| Atorvastatin | 19 | $360 | $19 |
| Omeprazole | 37 | $322 | $9 |
| Nifedipine Er | 12 | $279 | $23 |
| Simvastatin | 45 | $261 | $6 |
| Levothyroxine | 17 | $234 | $14 |
| Losartan | 15 | $231 | $15 |
| Lisinopril-Hydrochlorothiazide | 30 | $224 | $7 |
| Lisinopril | 54 | $209 | $4 |
| Fluticasone Propionate | 12 | $193 | $16 |
| Gabapentin | 16 | $173 | $11 |
| Ibuprofen | 17 | $118 | $7 |
| Naproxen | 20 | $116 | $6 |
| Amlodipine Besylate | 23 | $86 | $4 |
| Atenolol | 20 | $60 | $3 |
| Hydrochlorothiazide | 15 | $44 | $3 |
| Single Use Swab | 11 | $29 | $3 |
2013: 8 drugs
| Atorvastatin | 12 | $413 | $34 |
| Omeprazole | 15 | $307 | $20 |
| Simvastatin | 26 | $223 | $9 |
| Lisinopril-Hydrochlorothiazide | 14 | $148 | $11 |
| Lisinopril | 26 | $144 | $6 |
| Metformin | 20 | $124 | $6 |
| Glipizide | 11 | $95 | $9 |
| Metoprolol | 15 | $69 | $5 |
Money from drug and device companies
$266 in 2025
| 2025 | 3 | 3 | None | $266 |
| 2023 | 3 | 3 | None | $320 |
| 2022 | 4 | 6 | None | $516 |
| 2021 | 2 | 2 | None | $194 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ViiV Healthcare | Apretude | $122 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $108 | 1 payment
|
| Pacira Pharmaceuticals | Exparel | $36 | 1 payment
|
See all 3 published payments
| Pacira Pharmaceuticals | Meals · 2025-08-28 | Exparel | $36 |
| ViiV Healthcare | Meals · 2025-08-27 | Apretude | $122 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-19 | Fasenra | $108 |
See earlier years (2023, 2022, 2021)
2023: $320
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $116 | 1 payment
|
| Abbvie | Vraylar | $111 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $93 | 1 payment
|
2022: $516
| Amgen | Lumakras | $308 | 3 payments
|
| Vertos Medical | Mild Device Kit | $128 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $60 | 1 payment
|
| Supernus Pharmaceuticals | Trokendi Xr | $20 | 1 payment
|
2021: $194
| Amgen | Repatha | $102 | 1 payment
|
| AbbVie | Ubrelvy | $92 | 1 payment
|
Professional record
- NPI
- 1104132836
- Licence
- CA 57397California G57397: Current · expires 2028-01-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant, medical (363AM0700X)
- Mailing address
- 110 Sutter St Fl 6, San Francisco, CA, 94104
- NPI first listed
- 2010-08-18
- NPI last updated
- 2023-07-18
- NPI record certified
- 2023-07-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 590 Forest Ave, Palo Alto, CA, 94301